{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:31:42Z","timestamp":1793417502487,"version":"4.5.0"},"reference-count":146,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Major Science and Technology projects of Inner Mongolia Autonomous Region","award":["2024DXZD0001"],"award-info":[{"award-number":["2024DXZD0001"]}]},{"name":"Clinical medical research and clinical new technology promotion project of Inner Mongolia Physicians Associationt","award":["YSXH2024KYF001"],"award-info":[{"award-number":["YSXH2024KYF001"]}]},{"name":"Scientific research joint fund of public hospital of Inner Mongolia Academy of Medical Sciences","award":["2023GLLH0060"],"award-info":[{"award-number":["2023GLLH0060"]}]},{"name":"Medical and Health Science and Technology Program of the Health Commission of Inner Mongolia Autonomous Region","award":["202201054"],"award-info":[{"award-number":["202201054"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00203-026-04796-8","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:17:26Z","timestamp":1773757046000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Brucellosis vaccine development: immunological mechanisms, animal models, and future directions"],"prefix":"10.1007","volume":"208","author":[{"given":"Yi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yansong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"issue":"1","key":"4796_CR1","volume":"7","author":"EW Abd El-Wahab","year":"2025","unstructured":"Abd El-Wahab EW (2025) A scoping review of the national strategy for brucellosis control in Egypt: logic framework, challenges, and prospects. One Health Outlook 7(1):42","journal-title":"One Health Outlook"},{"key":"4796_CR2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.imlet.2019.01.010","volume":"207","author":"M Abkar","year":"2019","unstructured":"Abkar M, Alamian S, Sattarahmady N (2019) A comparison between adjuvant and delivering functions of calcium phosphate, aluminum hydroxide and chitosan nanoparticles, using a model protein of Brucella melitensis Omp31. Immunol Lett 207:28\u201335","journal-title":"Immunol Lett"},{"issue":"1","key":"4796_CR3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.7774\/cevr.2022.11.1.53","volume":"11","author":"A Al-Mariri","year":"2022","unstructured":"Al-Mariri A, Al-Hallab L, Alabras R, Kherbik H, Khawajkiah M (2022) Protection against virulent Brucella spp. by gamma-irradiated B. ovis in BALB\/c mice model. Clin Exp Vaccine Res 11(1):53\u201362","journal-title":"Clin Exp Vaccine Res"},{"issue":"9","key":"4796_CR4","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.2460\/ajvr.1972.33.09.1747","volume":"33","author":"GG Alton","year":"1972","unstructured":"Alton GG, Jones LM, Garc\u00eda-Carrillo C, Trenchi A (1972) Brucella melitensis Rev. 1 and Brucella abortus 45\u2009\u2013\u200920 vaccines in goats: immunity. Am J Vet Res 33(9):1747\u20131751","journal-title":"Am J Vet Res"},{"issue":"2","key":"4796_CR5","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1128\/IAI.01017-08","volume":"77","author":"AM Arenas-Gamboa","year":"2009","unstructured":"Arenas-Gamboa AM, Ficht TA, Kahl-Mcdonagh MM, Gomez G, Rice-Ficht AC (2009) The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB\/c mice when delivered in a sustained-release vehicle. Infect Immun 77(2):877\u2013884","journal-title":"Infect Immun"},{"issue":"2","key":"4796_CR6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1128\/CVI.05321-11","volume":"19","author":"AM Arenas-Gamboa","year":"2012","unstructured":"Arenas-Gamboa AM, Rice-Ficht AC, Fan Y, Kahl-Mcdonagh MM, Ficht TA (2012) Extended safety and efficacy studies of the attenuated Brucella vaccine candidates 16\u00a0M(Delta)vjbR and S19(Delta)vjbR in the immunocompromised IRF-1-\/- mouse model. Clin Vaccine Immunol 19(2):249\u2013260","journal-title":"Clin Vaccine Immunol"},{"issue":"9","key":"4796_CR7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri3495","volume":"13","author":"JS Arthur","year":"2013","unstructured":"Arthur JS, Ley SC (2013) Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol 13(9):679\u2013692","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"4796_CR8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12917-021-02782-4","volume":"17","author":"R Aruho","year":"2021","unstructured":"Aruho R, Macleod ET, Manirakiza L, Rwego I (2021) B. A serological survey of brucellosis in wildlife in four major National Parks of Uganda. BMC Vet Res 17(1):95","journal-title":"BMC Vet Res"},{"key":"4796_CR9","doi-asserted-by":"crossref","DOI":"10.1177\/11779322241272404","volume":"18","author":"M Asadinezhad","year":"2024","unstructured":"Asadinezhad M, Pakzad I, Asadollahi P, Ghafourian S, Kalani BS (2024) Proteomics exploration of Brucella melitensis to design an innovative multi-epitope mRNA vaccine. Bioinform Biol Insights 18:11779322241272404","journal-title":"Bioinform Biol Insights"},{"issue":"4","key":"4796_CR10","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1128\/cdli.3.4.472-476.1996","volume":"3","author":"PC Baldi","year":"1996","unstructured":"Baldi PC, Giambartolomei GH, Goldbaum FA, Abd\u00f3n LF, Velikovsky CA, Kittelberger R, Fossati CA (1996) Humoral immune response against lipopolysaccharide and cytoplasmic proteins of Brucella abortus in cattle vaccinated with B. abortus S19 or experimentally infected with Yersinia enterocolitica serotype 0:9. Clin Diagn Lab Immunol 3(4):472\u2013476","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1\u20134","key":"4796_CR11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0378-1135(02)00231-6","volume":"90","author":"M Banai","year":"2002","unstructured":"Banai M (2002) Control of small ruminant brucellosis by use of Brucella melitensis Rev.1 vaccine: laboratory aspects and field observations. Vet Microbiol 90(1\u20134):497\u2013519","journal-title":"Vet Microbiol"},{"key":"4796_CR12","volume":"4","author":"M Banai","year":"2017","unstructured":"Banai M, Itin R, Bardenstein S (2017) Perspectives and outcomes of the activity of a reference laboratory for Brucellosis. Front Vet Sci 4:234","journal-title":"Front Vet Sci"},{"issue":"4","key":"4796_CR13","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/JCM.40.2.1475-1480.2002","volume":"40","author":"S Bardenstein","year":"2002","unstructured":"Bardenstein S, Mandelboim M, Ficht TA, Baum M, Banai M (2002) Identification of the Brucella melitensis vaccine strain Rev.1 in animals and humans in Israel by PCR analysis of the PstI site polymorphism of its omp2 gene. J Clin Microbiol 40(4):1475\u20131480","journal-title":"J Clin Microbiol"},{"key":"4796_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/foods11152269","author":"A B\u00e9jaoui","year":"2022","unstructured":"B\u00e9jaoui A, Ben Abdallah I, Maaroufi A (2022) Brucella spp. contamination in artisanal unpasteurized dairy products: an emerging foodborne threat in Tunisia. Foods. https:\/\/doi.org\/10.3390\/foods11152269","journal-title":"Foods"},{"issue":"1","key":"4796_CR15","doi-asserted-by":"crossref","DOI":"10.1186\/s12917-023-03773-3","volume":"19","author":"JM Blasco","year":"2023","unstructured":"Blasco JM, Moreno E, Mu\u00f1oz PM, Conde-\u00c1lvarez R, Moriy\u00f3n I (2023) A review of three decades of use of the cattle brucellosis rough vaccine Brucella abortus RB51: myths and facts. BMC Vet Res 19(1):211","journal-title":"BMC Vet Res"},{"issue":"3\u20134","key":"4796_CR16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0167-5877(96)01110-5","volume":"31","author":"JM Blasco","year":"1997","unstructured":"Blasco JM (1997) A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats. Prev Vet Med 31(3\u20134):275\u2013283","journal-title":"Prev Vet Med"},{"issue":"4","key":"4796_CR17","first-page":"354","volume":"59","author":"N Bosseray","year":"1978","unstructured":"Bosseray N (1978) Immunity to Brucella in mice vaccinated with a fraction (F8) or a killed vaccine (H38) with or without adjuvant. Level and duration of immunity in relation to dose of vaccine, recall injection and age of mice. Br J Exp Pathol 59(4):354\u2013365","journal-title":"Br J Exp Pathol"},{"issue":"4","key":"4796_CR18","doi-asserted-by":"crossref","first-page":"758","DOI":"10.14202\/vetworld.2020.758-763","volume":"13","author":"F Bouchemla","year":"2019","unstructured":"Bouchemla F, Agoltsov VA, Veselovsky SY, Larionov SV, Popova OM (2019) Krivenko D. V. Clinical results of an inactivated anti-brucella vaccine in combination with immunomodulators. Vet World 13(4):758\u2013763","journal-title":"Vet World"},{"issue":"3","key":"4796_CR19","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.ymthe.2025.01.008","volume":"33","author":"M Buckley","year":"2025","unstructured":"Buckley M, Ara\u00ednga M, Maiorino L, Pires IS, Kim BJ, Michaels KK, Dye J, Qureshi K, Zhang YJ, Mak H, Steichen JM, Schief WR, Villinger F, Irvine DJ (2025) Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primates. Mol Ther 33(3):1105\u20131117","journal-title":"Mol Ther"},{"issue":"7","key":"4796_CR20","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.14202\/vetworld.2020.1439-1447","volume":"13","author":"A Bulashev","year":"2020","unstructured":"Bulashev A, Akibekov O, Syzdykova A, Suranshiyev Z, Ingirbay B (2020) Use of recombinant Brucella outer membrane proteins 19, 25, and 31 for serodiagnosis of bovine brucellosis. Vet World 13(7):1439\u20131447","journal-title":"Vet World"},{"issue":"1","key":"4796_CR21","first-page":"13","volume":"46","author":"V Caporale","year":"2010","unstructured":"Caporale V, Bonfini B, Di Giannatale E, Di Provvido A, Forcella S, Giovannini A, Tittarelli M, Scacchia M (2010) Efficacy of Brucella abortus vaccine strain RB51 compared to the reference vaccine Brucella abortus strain 19 in water buffalo. Vet Ital 46(1):13\u201319 15\u2009\u2013\u200911","journal-title":"Vet Ital"},{"issue":"12","key":"4796_CR22","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1128\/IAI.73.12.8079-8088.2005","volume":"73","author":"J Cassataro","year":"2005","unstructured":"Cassataro J, Estein SM, Pasquevich KA, Velikovsky CA, De La Barrera S, Bowden R, Fossati CA, Giambartolomei GH (2005) Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4\u2009+\u2009T helper 1 response that protects against Brucella melitensis infection. Infect Immun 73(12):8079\u20138088","journal-title":"Infect Immun"},{"issue":"3","key":"4796_CR23","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.vaccine.2020.11.033","volume":"39","author":"MR Casta\u00f1o-Zubieta","year":"2021","unstructured":"Casta\u00f1o-Zubieta MR, Rossetti CA, Garc\u00eda-Gonz\u00e1lez DG, Maurizio E, Hensel ME, Rice-Ficht AC, Ficht TA, Arenas-Gamboa \u00c1M (2021) Evaluation of the safety profile of the vaccine candidate Brucella melitensis 16 M\u2206vjbR strain in goats. Vaccine 39(3):617\u2013625","journal-title":"Vaccine"},{"issue":"11","key":"4796_CR24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260288","volume":"16","author":"C Chac\u00f3n-D\u00edaz","year":"2021","unstructured":"Chac\u00f3n-D\u00edaz C, Zabalza-Barangu\u00e1 A, San Rom\u00e1n B, Blasco JM, Iriarte M, Salas-Alfaro D, Hern\u00e1ndez-Mora G, Barquero-Calvo E, Guzm\u00e1n-Verri C, Chaves-Olarte E, Grill\u00f3 MJ, Moreno E (2021) Brucella abortus S19 GFP-tagged vaccine allows the serological identification of vaccinated cattle. PLoS One 16(11):e0260288","journal-title":"PLoS One"},{"issue":"2 Suppl 2","key":"4796_CR25","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jaci.2009.12.980","volume":"125","author":"DD Chaplin","year":"2010","unstructured":"Chaplin DD (2010) Overview of the immune response. J Allergy Clin Immunol 125(2 Suppl 2):S3\u201323","journal-title":"J Allergy Clin Immunol"},{"key":"4796_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9121423","author":"P Chaudhuri","year":"2021","unstructured":"Chaudhuri P, Saminathan M, Ali SA, Kaur G, Singh SV, Lalsiamthara J, Goswami TK, Singh AK, Singh SK, Malik P, Singh RK (2021) Immunization with Brucella abortus S19\u0394per conferred protection in water buffaloes against virulent challenge with B. abortus strain S544. Vaccines. https:\/\/doi.org\/10.3390\/vaccines9121423","journal-title":"Vaccines"},{"key":"4796_CR27","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1017\/S0950268821001229","volume":"149","author":"Z Chen","year":"2021","unstructured":"Chen Z, Zhu Y, Sha T, Li Z, Li Y, Zhang F, Ding J (2021) Design of a new multi-epitope vaccine against Brucella based on T and B cell epitopes using bioinformatics methods. Epidemiol Infect 149:e136","journal-title":"Epidemiol Infect"},{"issue":"10","key":"4796_CR28","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","volume":"65","author":"X Chen","year":"2013","unstructured":"Chen X, Zaro JL, Shen WC (2013) Fusion protein linkers: property, design and functionality. Adv Drug Deliv Rev 65(10):1357\u20131369","journal-title":"Adv Drug Deliv Rev"},{"issue":"13\u201314","key":"4796_CR29","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/S0264-410X(02)00035-X","volume":"20","author":"A Cloeckaert","year":"2002","unstructured":"Cloeckaert A, Zygmunt MS, Guilloteau LA (2002) Brucella abortus vaccine strain RB51 produces low levels of M-like O-antigen. Vaccine 20(13\u201314):1820\u20131822","journal-title":"Vaccine"},{"issue":"2","key":"4796_CR30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3201\/eid0302.970219","volume":"3","author":"MJ Corbel","year":"1997","unstructured":"Corbel MJ (1997) Brucellosis: an overview. Emerg Infect Dis 3(2):213\u2013221","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"4796_CR31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002193","volume":"3","author":"OR Crasta","year":"2008","unstructured":"Crasta OR, Folkerts O, Fei Z, Mane SP, Evans C, Martino-Catt S, Bricker B, Yu G, Du L, Sobral BW (2008) Genome sequence of Brucella abortus vaccine strain S19 compared to virulent strains yields candidate virulence genes. PLoS One 3(5):e2193","journal-title":"PLoS One"},{"key":"4796_CR32","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2023.1105485","volume":"10","author":"L Crawford","year":"2023","unstructured":"Crawford L, Falkenberg S, Putz EJ, Olsen S, Boggiatto PM (2023) Effects of concurrent administration of modified live viral vaccines with RB51 on immune responses to RB51. Front Vet Sci 10:1105485","journal-title":"Front Vet Sci"},{"issue":"9","key":"4796_CR33","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3855\/jidc.2019","volume":"5","author":"MM D\u2019elios","year":"2011","unstructured":"D\u2019elios MM, Benagiano M, Della Bella C, Amedei A (2011) T-cell response to bacterial agents. J Infect Dev Ctries 5(9):640\u2013645","journal-title":"J Infect Dev Ctries"},{"issue":"1","key":"4796_CR34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/01652176.2021.1894501","volume":"41","author":"M Dadar","year":"2021","unstructured":"Dadar M, Tiwari R, Sharun K, Dhama K (2021) Importance of brucellosis control programs of livestock on the improvement of one health. Vet Q 41(1):137\u2013151","journal-title":"Vet Q"},{"issue":"14","key":"4796_CR35","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e34324","volume":"10","author":"M Dadar","year":"2024","unstructured":"Dadar M, Al-Khaza\u2019leh J, Fakhri Y, Akar K, Ali S, Shahali Y (2024) Human brucellosis and associated risk factors in the Middle East region: a comprehensive systematic review, meta-analysis, and meta-regression. Heliyon 10(14):e34324","journal-title":"Heliyon"},{"key":"4796_CR36","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2024.107436","volume":"260","author":"M Dadar","year":"2024","unstructured":"Dadar M, Bahreinipour A, Abnaroodheleh F, Ansari F, Mousavi Khaneghah A (2024) Risk factors and control strategies for Brucella spp. and RB51 vaccine shedding in buffalo milk: a cross-sectional study. Acta Trop 260:107436","journal-title":"Acta Trop"},{"key":"4796_CR37","doi-asserted-by":"crossref","first-page":"903890","DOI":"10.3389\/fvets.2022.903890","volume":"9","author":"A Darbandi","year":"2022","unstructured":"Darbandi A, Alamdary SZ, Koupaei M, Ghanavati R, Heidary M, Talebi M (2022) Evaluation of immune responses to Brucella vaccines in mouse models: A systematic review. Front Vet Sci 9:903890","journal-title":"Front Vet Sci"},{"issue":"1\u20134","key":"4796_CR38","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0378-1135(02)00233-X","volume":"90","author":"DS Davis","year":"2002","unstructured":"Davis DS, Elzer PH (2002) Brucella vaccines in wildlife. Vet Microbiol 90(1\u20134):533\u2013544","journal-title":"Vet Microbiol"},{"issue":"4","key":"4796_CR39","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1111\/tbed.14259","volume":"69","author":"MM De Oliveira","year":"2022","unstructured":"De Oliveira MM, Pereira CR, De Oliveira IRC, Godfroid J, Lage AP, Dorneles EMS (2022) Efficacy of Brucella abortus S19 and RB51 vaccine strains: a systematic review and meta-analysis. Transbound Emerg Dis 69(4):e32\u2013e51","journal-title":"Transbound Emerg Dis"},{"issue":"5","key":"4796_CR40","first-page":"564","volume":"26","author":"X Deng","year":"2023","unstructured":"Deng X, He J, Xu J, Wang Y, Yi J, Zhang H, Wang Y, Wang Z, Chen C (2023) LDH as an adjuvant makes Brucella outer-membrane vesicles and outer-membrane vesicle-associated proteins highly protective in mice. Iran J Basic Med Sci 26(5):564\u2013571","journal-title":"Iran J Basic Med Sci"},{"issue":"Suppl 5","key":"4796_CR41","doi-asserted-by":"crossref","first-page":"F17","DOI":"10.1016\/j.vaccine.2010.03.054","volume":"28","author":"AA Denisov","year":"2010","unstructured":"Denisov AA, Korobovtseva YS, Karpova OM, Tretyakova AV, Mikhina LV, Ivanov AV, Salmakov KM, Borovick RV (2010) Immunopotentiation of live brucellosis vaccine by adjuvants. Vaccine 28(Suppl 5):F17\u201322","journal-title":"Vaccine"},{"issue":"2","key":"4796_CR42","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2249126","volume":"12","author":"V Djokic","year":"2023","unstructured":"Djokic V, Freddi L, De Massis F, Lahti E, Van Den Esker MH, Whatmore A, Haughey A, Ferreira AC, Garofolo G, Melzer F, Sacchini F, Koets A, Wyllie S, Fontbonne A, Girault G, Vicente AF, Mcgiven J, Ponsart C (2023) The emergence of Brucella canis as a public health threat in Europe: what we know and what we need to learn. Emerg Microbes Infect 12(2):2249126","journal-title":"Emerg Microbes Infect"},{"issue":"1\u20134","key":"4796_CR43","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0378-1135(02)00223-7","volume":"90","author":"J Dornand","year":"2002","unstructured":"Dornand J, Gross A, Lafont V, Liautard J, Oliaro J, Liautard JP (2002) The innate immune response against Brucella in humans. Vet Microbiol 90(1\u20134):383\u2013394","journal-title":"Vet Microbiol"},{"issue":"1","key":"4796_CR44","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13567-015-0199-7","volume":"46","author":"EM Dorneles","year":"2015","unstructured":"Dorneles EM, Sriranganathan N, Lage AP (2015) Recent advances in Brucella abortus vaccines. Vet Res 46(1):76","journal-title":"Vet Res"},{"issue":"9","key":"4796_CR45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136696","volume":"10","author":"EM Dorneles","year":"2015","unstructured":"Dorneles EM, Lima GK, Teixeira-Carvalho A, Ara\u00fajo MS, Martins-Filho OA, Sriranganathan N, Al Qublan H, Heinemann MB, Lage AP (2015) Immune response of calves vaccinated with Brucella abortus S19 or RB51 and revaccinated with RB51. PLoS One 10(9):e0136696","journal-title":"PLoS One"},{"issue":"4","key":"4796_CR46","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/tbed.14442","volume":"69","author":"EMS Dorneles","year":"2022","unstructured":"Dorneles EMS, Lage AP, Bueno Filho JSS, Godfroid J, Pereira CR (2022) Efficacy of bovine brucellosis vaccines: conceptions, challenges and meta-analysis. Response to the Letter to the Editor concerning \u201cEfficacy of Brucella abortus S19 and RB51 vaccine strains: A systematic review and meta-analysis\u201d by Blasco et al (Transbound Emerg Dis; 2021: doi: 10.1111\/tbed.14259). Transbound Emerg Dis 69(4):1674\u20131677","journal-title":"Transbound Emerg Dis"},{"issue":"4","key":"4796_CR47","first-page":"405","volume":"48","author":"M Ebrahimi","year":"2012","unstructured":"Ebrahimi M, Nejad RB, Alamian S, Mokhberalsafa L, Abedini F, Ghaderi R, Jalali HR (2012) Safety and efficacy of reduced doses of Brucella melitensis strain Rev. 1 vaccine in pregnant Iranian fat-tailed ewes. Vet Ital 48(4):405\u2013412","journal-title":"Vet Ital"},{"issue":"3","key":"4796_CR48","doi-asserted-by":"crossref","first-page":"741","DOI":"10.20506\/rst.20.3.1305","volume":"20","author":"AH El Idrissi","year":"2001","unstructured":"El Idrissi AH, Benkirane A, El Maadoudi M, Bouslikhane M, Berrada J, Zerouali A (2001) Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes. Rev Sci Tech 20(3):741\u2013747","journal-title":"Rev Sci Tech"},{"key":"4796_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12050866","author":"A Elizalde-Bielsa","year":"2024","unstructured":"Elizalde-Bielsa A, Mu\u00f1oz PM, Z\u00fa\u00f1iga-Ripa A, Conde-\u00c1lvarez R (2024) A review on the methodology and use of the pregnant mouse model in the study of Brucella reproductive pathogenesis and its abortifacient effect. Microorganisms. https:\/\/doi.org\/10.3390\/microorganisms12050866","journal-title":"Microorganisms"},{"issue":"10","key":"4796_CR50","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.4161\/hv.29594","volume":"10","author":"H Fausther-Bovendo","year":"2014","unstructured":"Fausther-Bovendo H, Kobinger GP (2014) Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what\u2019s important? Hum Vaccin Immunother 10(10):2875\u20132884","journal-title":"Hum Vaccin Immunother"},{"issue":"Suppl 4","key":"4796_CR51","doi-asserted-by":"crossref","first-page":"D40","DOI":"10.1016\/j.vaccine.2009.08.058","volume":"27","author":"TA Ficht","year":"2009","unstructured":"Ficht TA, Kahl-Mcdonagh MM, Arenas-Gamboa AM, Rice-Ficht AC (2009) Brucellosis: the case for live, attenuated vaccines. Vaccine 27(Suppl 4):D40\u201343","journal-title":"Vaccine"},{"issue":"1","key":"4796_CR52","doi-asserted-by":"crossref","DOI":"10.1186\/s12865-025-00728-1","volume":"26","author":"H Gharazi","year":"2025","unstructured":"Gharazi H, Doosti A, Abdizadeh R (2025) Brucellosis novel multi-epitope vaccine design based on in silico analysis focusing on Brucella abortus. BMC Immunol 26(1):46","journal-title":"BMC Immunol"},{"issue":"1","key":"4796_CR53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.20506\/rst.32.1.2180","volume":"32","author":"J Godfroid","year":"2013","unstructured":"Godfroid J, Garin-Bastuji B, Saegerman C, Blasco JM (2013) Brucellosis in terrestrial wildlife. Rev Sci Tech 32(1):27\u201342","journal-title":"Rev Sci Tech"},{"key":"4796_CR54","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1565688","volume":"16","author":"FM Gonz\u00e1lez","year":"2025","unstructured":"Gonz\u00e1lez FM, Bialer MG, Cerutti ML, Estein SM, Ramis LY, Baldi PC, Zorreguieta \u00c1, Ferrero MC (2025) Corrigendum: Brucella suis \u0394mapB outer membrane vesicles as an acellular vaccine against systemic and mucosal B. suis infection. Front Immunol 16:1565688","journal-title":"Front Immunol"},{"issue":"2","key":"4796_CR55","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.vaccine.2008.10.065","volume":"27","author":"MJ Grill\u00f3","year":"2009","unstructured":"Grill\u00f3 MJ, Mar\u00edn CM, Barber\u00e1n M, De Miguel MJ, Laroucau K, Jacques I, Blasco JM (2009) Efficacy of bp26 and bp26\/omp31 B. melitensis Rev.1 deletion mutants against Brucella ovis in rams. Vaccine 27(2):187\u2013191","journal-title":"Vaccine"},{"issue":"1","key":"4796_CR56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1297-9716-43-29","volume":"43","author":"MJ Grill\u00f3","year":"2012","unstructured":"Grill\u00f3 MJ, Blasco JM, Gorvel JP, Moriy\u00f3n I, Moreno E (2012) What have we learned from brucellosis in the mouse model? Vet Res 43(1):29","journal-title":"Vet Res"},{"issue":"15","key":"4796_CR57","doi-asserted-by":"crossref","first-page":"482","DOI":"10.15585\/mmwr.mm6915a4","volume":"69","author":"JF Gruber","year":"2020","unstructured":"Gruber JF, Newman A, Egan C, Campbell C, Garafalo K, Wolfgang DR, Weltman A, Kline KE, Watkins SM, Robbe-Austerman S, Quance C, Thacker T, Kharod G, Negron ME, Schroeder B (2020) Notes from the field: Brucella abortus RB51 infections associated with consumption of raw milk from Pennsylvania\u2009\u2013\u20092017 and 2018. MMWR Morb Mortal Wkly Rep 69(15):482\u2013483","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4796_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9020152","author":"S Gupta","year":"2020","unstructured":"Gupta S, Mohan S, Somani VK, Aggarwal S, Bhatnagar R (2020) Simultaneous immunization with Omp25 and L7\/L12 provides protection against brucellosis in mice. Pathogens. https:\/\/doi.org\/10.3390\/pathogens9020152","journal-title":"Pathogens"},{"key":"4796_CR59","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftaa002","author":"S Gupta","year":"2019","unstructured":"Gupta S, Singh D, Gupta M, Bhatnagar R (2019) A combined subunit vaccine comprising BP26, Omp25 and L7\/L12 against brucellosis. Pathog Dis. https:\/\/doi.org\/10.1093\/femspd\/ftaa002","journal-title":"Pathog Dis"},{"key":"4796_CR60","doi-asserted-by":"crossref","unstructured":"Gunes H, Dogan M (2013) False-positivity in diagnosis of brucellosis associated with Rev-1 vaccine. Libyan J Med, 8","DOI":"10.3402\/ljm.v8i0.20417"},{"issue":"4","key":"4796_CR61","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3325\/cmj.2010.51.289","volume":"51","author":"M Gwida","year":"2010","unstructured":"Gwida M, Al Dahouk S, Melzer F, R\u00f6sler U, Neubauer H, Tomaso H (2010) Brucellosis - regionally emerging zoonotic disease? Croat Med J 51(4):289\u2013295","journal-title":"Croat Med J"},{"issue":"2","key":"4796_CR62","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/BA20000034","volume":"32","author":"M Hansson","year":"2000","unstructured":"Hansson M, Nygren PA, St\u00e5hl S (2000) Design and production of recombinant subunit vaccines. Biotechnol Appl Biochem 32(2):95\u2013107","journal-title":"Biotechnol Appl Biochem"},{"issue":"9","key":"4796_CR63","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1128\/IAI.69.9.5502-5508.2001","volume":"69","author":"Y He","year":"2001","unstructured":"He Y, Vemulapalli R, Zeytun A, Schurig GG (2001) Induction of specific cytotoxic lymphocytes in mice vaccinated with Brucella abortus RB51. Infect Immun 69(9):5502\u20135508","journal-title":"Infect Immun"},{"key":"4796_CR64","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.925773","volume":"9","author":"M Heidary","year":"2022","unstructured":"Heidary M, Dashtbin S, Ghanavati R, Mahdizade Ari M, Bostanghadiri N, Darbandi A, Navidifar T, Talebi M (2022) Evaluation of brucellosis vaccines: a comprehensive review. Front Vet Sci 9:925773","journal-title":"Front Vet Sci"},{"issue":"5","key":"4796_CR65","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1039\/D4CB00022F","volume":"5","author":"LLY Ho","year":"2024","unstructured":"Ho LLY, Schiess GHA, Miranda P, Weber G, Astakhova K (2024) Pseudouridine and N1-methylpseudouridine as potent nucleotide analogues for RNA therapy and vaccine development. RSC Chem Biol 5(5):418\u2013425","journal-title":"RSC Chem Biol"},{"key":"4796_CR66","volume":"187","author":"R Hu","year":"2025","unstructured":"Hu R, Zhang Q, Wang W, Ren W, Yao M, Xu Y, Zhang H, Sheng J, Wang Y, Chen C, Ma Z (2025) Brucella inactivated vaccine elicits immunity against B. melitensis infection in mice and guinea pigs. Biomed Pharmacother 187:118077","journal-title":"Biomed Pharmacother"},{"key":"4796_CR67","doi-asserted-by":"crossref","unstructured":"Hensel ME, Garcia-Gonzalez DG, Chaki SP, Hartwig A, Gordy PW, Bowen R, Ficht TA, Arenas-Gamboa AM (2020) Vaccine Candidate Brucella melitensis 16\u00a0M\u2206vjbR Is Safe in a Pregnant Sheep Model and Confers Protection. mSphere, 5(3)","DOI":"10.1128\/mSphere.00120-20"},{"issue":"10","key":"4796_CR68","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.14202\/vetworld.2023.2080-2085","volume":"16","author":"M Ibarra","year":"2023","unstructured":"Ibarra M, Campos M, Loor-Giler Hern\u00e1nB, Chamorro A, Nu\u00f1ez A (2023) Comparison of diagnostic tests for detecting bovine brucellosis in animals vaccinated with S19 and RB51 strain vaccines. Vet World 16(10):2080\u20132085","journal-title":"Vet World"},{"issue":"2","key":"4796_CR69","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s12026-022-09346-0","volume":"71","author":"K Jalal","year":"2023","unstructured":"Jalal K, Khan K, Uddin R (2023) Immunoinformatic-guided designing of multi-epitope vaccine construct against Brucella Suis 1300. Immunol Res 71(2):247\u2013266","journal-title":"Immunol Res"},{"issue":"5","key":"4796_CR70","first-page":"392","volume":"3","author":"MM Khatun","year":"2009","unstructured":"Khatun MM, Islam MA, Baek BK, Lee SI (2009) Characteristics of the immune response during acute brucellosis in Sprague-Dawley rats. J Infect Dev Ctries 3(5):392\u2013397","journal-title":"J Infect Dev Ctries"},{"issue":"11","key":"4796_CR71","doi-asserted-by":"crossref","DOI":"10.5812\/jjm.24853","volume":"8","author":"Z Kianmehr","year":"2015","unstructured":"Kianmehr Z, Kaboudanian Ardestani S, Soleimanjahi H, Fotouhi F, Alamian S, Ahmadian S (2015) Comparison of biological and immunological characterization of lipopolysaccharides from Brucella abortus RB51 and S19. Jundishapur J Microbiol 8(11):e24853","journal-title":"Jundishapur J Microbiol"},{"issue":"S1","key":"4796_CR72","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4142\/jvs.2017.18.S1.281","volume":"18","author":"J Lalsiamthara","year":"2017","unstructured":"Lalsiamthara J, Lee JH (2017) Development and trial of vaccines against Brucella. J Vet Sci 18(S1):281\u2013290","journal-title":"J Vet Sci"},{"key":"4796_CR73","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.biologicals.2019.11.005","volume":"63","author":"J Lalsiamthara","year":"2020","unstructured":"Lalsiamthara J, Kaur G, Gogia N, Ali SA, Goswami TK, Chaudhuri P (2020) Brucella abortus S19 rfbD mutant is highly attenuated, DIVA enable and confers protection against virulent challenge in mice. Biologicals 63:62\u201367","journal-title":"Biologicals"},{"issue":"22","key":"4796_CR74","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1016\/j.vaccine.2015.04.004","volume":"33","author":"J Lalsiamthara","year":"2015","unstructured":"Lalsiamthara J, Gogia N, Goswami TK, Singh RK, Chaudhuri P (2015) Intermediate rough Brucella abortus S19\u2206per mutant is DIVA enable, safe to pregnant guinea pigs and confers protection to mice. Vaccine 33(22):2577\u20132583","journal-title":"Vaccine"},{"issue":"7","key":"4796_CR75","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1128\/IAI.00403-13","volume":"81","author":"JJ Lee","year":"2013","unstructured":"Lee JJ, Kim DH, Kim DG, Lee HJ, Min W, Rhee MH, Cho JY, Watarai M, Kim S (2013) Toll-like receptor 4-linked Janus kinase 2 signaling contributes to internalization of Brucella abortus by macrophages. Infect Immun 81(7):2448\u20132458","journal-title":"Infect Immun"},{"issue":"2","key":"4796_CR76","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4110\/in.2015.15.2.51","volume":"15","author":"S Lee","year":"2015","unstructured":"Lee S, Nguyen MT (2015) Recent advances of vaccine adjuvants for infectious diseases. Immune Netw 15(2):51\u201357","journal-title":"Immune Netw"},{"issue":"6","key":"4796_CR77","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1111\/1751-7915.14015","volume":"15","author":"Z Li","year":"2022","unstructured":"Li Z, Wang S, Wei S, Yang G, Zhang C, Xi L, Zhang J, Cui Y, Hao J, Zhang H, Zhang H (2022) Immunization with a combination of recombinant Brucella abortus proteins induces T helper immune response and confers protection against wild-type challenge in BALB\/c mice. Microb Biotechnol 15(6):1811\u20131823","journal-title":"Microb Biotechnol"},{"issue":"2","key":"4796_CR78","doi-asserted-by":"crossref","first-page":"738","DOI":"10.7150\/thno.84291","volume":"14","author":"X Li","year":"2024","unstructured":"Li X, Qi J, Wang J, Hu W, Zhou W, Wang Y, Li T (2024) Nanoparticle technology for mRNA: delivery strategy, clinical application and developmental landscape. Theranostics 14(2):738\u2013760","journal-title":"Theranostics"},{"key":"4796_CR79","volume":"2024","author":"LM Li","year":"2024","unstructured":"Li LM, Xiang WT, Li T, Xiang MM, Liu F, Li JM (2024) Efficacy of Brucella vaccines in sheep: a systematic review and meta-analysis. Transbound Emerg Dis 2024:5524768","journal-title":"Transbound Emerg Dis"},{"issue":"3","key":"4796_CR80","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4142\/jvs.2012.13.3.287","volume":"13","author":"JJ Lim","year":"2012","unstructured":"Lim JJ, Kim DH, Lee JJ, Kim DG, Min W, Lee HJ, Rhee MH, Kim S (2012) Protective effects of recombinant Brucella abortus Omp28 against infection with a virulent strain of Brucella abortus 544 in mice. J Vet Sci 13(3):287\u2013292","journal-title":"J Vet Sci"},{"key":"4796_CR81","volume":"158","author":"X Liu","year":"2025","unstructured":"Liu X, Xiu C, He L, Zhao Y, Li B (2025) Strong immune response and protection against Brucella abortus by Omp25 and BP26 mRNA vaccine candidates. Int Immunopharmacol 158:114765","journal-title":"Int Immunopharmacol"},{"key":"4796_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251810166","author":"Y Liu","year":"2024","unstructured":"Liu Y, Huang Y, He G, Guo C, Dong J, Wu L (2024) Development of mRNA lipid nanoparticles: targeting and therapeutic aspects. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms251810166","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4796_CR83","volume":"28","author":"D Liu","year":"2024","unstructured":"Liu D, Chen Y (2024) Epitope screening and vaccine molecule design of PRRSV GP3 and GP5 protein based on immunoinformatics. J Cell Mol Med 28(3):e18103","journal-title":"J Cell Mol Med"},{"issue":"3","key":"4796_CR84","doi-asserted-by":"crossref","first-page":"e17425","DOI":"10.1371\/journal.pone.0017425","volume":"6","author":"JE Lowry","year":"2011","unstructured":"Lowry JE, Isaak DD, Leonhardt JA, Vernati G, Pate JC, Andrews GP (2011) Vaccination with Brucella abortus recombinant in vivo-induced antigens reduces bacterial load and promotes clearance in a mouse model for infection. PLoS ONE 6(3):e17425","journal-title":"PLoS ONE"},{"issue":"1","key":"4796_CR85","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12917-020-02453-w","volume":"16","author":"HO Lutta","year":"2020","unstructured":"Lutta HO, Odongo D, Mather A, Perez-Casal J, Potter A, Gerdts V, Berberov EM, Prysliak T, Kyallo M, Kipronoh A, Olum M, Pelle R, Naessens J (2020) Baseline analysis of Mycoplasma mycoides subsp. mycoides antigens as targets for a DIVA assay for use with a subunit vaccine for contagious bovine pleuropneumonia. BMC Vet Res 16(1):236","journal-title":"BMC Vet Res"},{"key":"4796_CR86","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fvets.2020.00058","volume":"7","author":"A Mailybayeva","year":"2020","unstructured":"Mailybayeva A, Ryskeldinova S, Zinina N, Zhou EM, Renukaradhya GJ, Tabynov K (2020) Evaluation of duration of immunogenicity and protective efficacy of improved influenza viral vector-based Brucella abortus vaccine against Brucella melitensis infection in sheep and goats. Front Vet Sci 7:58","journal-title":"Front Vet Sci"},{"key":"4796_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11020263","author":"M Malik","year":"2023","unstructured":"Malik M, Khan S, Ullah A, Hassan M, Haq MU, Ahmad S, Al-Harbi AI, Sanami S, Abideen SA, Irfan M, Khurram M (2023) Proteome-wide screening of potential vaccine targets against Brucella melitensis. Vaccines. https:\/\/doi.org\/10.3390\/vaccines11020263","journal-title":"Vaccines"},{"issue":"1\u20134","key":"4796_CR88","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0378-1135(02)00249-3","volume":"90","author":"JJ Mcdermott","year":"2002","unstructured":"Mcdermott JJ, Arimi SM (2002) Brucellosis in sub-Saharan Africa: epidemiology, control and impact. Vet Microbiol 90(1\u20134):111\u2013134","journal-title":"Vet Microbiol"},{"issue":"3","key":"4796_CR89","first-page":"1091","volume":"15","author":"DK Meles","year":"2025","unstructured":"Meles DK, Khairullah AR, Utama S, Wurlina W, Mulyati S, Mustofa I, Rimayanti R, Lestari TD, Moses IB, Wibowo S, Wardhani BWK, Kurniasih DAA, Kusala MKJ, Ahmad RZ, Fauziah I, Wasito W, Akintunde AO (2025) Jembrana disease in Indonesia: an updated review. Open Vet J 15(3):1091\u20131100","journal-title":"Open Vet J"},{"key":"4796_CR90","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.908495","volume":"13","author":"S Mena-Bueno","year":"2022","unstructured":"Mena-Bueno S, Poveda-Urkixo I, Irazoki O, Palacios L, Cava F, Zabalza-Barangu\u00e1 A, Grill\u00f3 MJ (2022) Brucella melitensis Wzm\/Wzt system: changes in the bacterial envelope lead to improved Rev1\u0394wzm vaccine properties. Front Microbiol 13:908495","journal-title":"Front Microbiol"},{"issue":"2","key":"4796_CR91","volume":"19","author":"\u00c2JF Mendes","year":"2025","unstructured":"Mendes \u00c2JF, Haydon DT, De Glanville WA, Bodenham RF, Lukambagire AS, Johnson PCD, Shirima GM, Cleaveland S, Mcintosh E, Hanley N, Halliday JEB (2025) Livestock production losses attributable to brucellosis in northern and central Tanzania: application of an epidemiological-economic modelling framework. PLoS Negl Trop Dis 19(2):e0012814","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"4796_CR92","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.prevetmed.2004.03.007","volume":"64","author":"A Minas","year":"2004","unstructured":"Minas A, Minas M, Stournara A, Tselepidis S (2004) The effects of Rev-1 vaccination of sheep and goats on human brucellosis in Greece. Prev Vet Med 64(1):41\u201347","journal-title":"Prev Vet Med"},{"issue":"4","key":"4796_CR93","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.vaccine.2014.11.056","volume":"33","author":"KL Miranda","year":"2015","unstructured":"Miranda KL, Dorneles EM, Pauletti RB, Poester FP, Lage AP (2015) Brucella abortus S19 and RB51 vaccine immunogenicity test: evaluation of three mice (BALB\/c, Swiss and CD-1) and two challenge strains (544 and 2308). Vaccine 33(4):507\u2013511","journal-title":"Vaccine"},{"issue":"5","key":"4796_CR94","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/vms3.537","volume":"7","author":"Y Mohammadi","year":"2021","unstructured":"Mohammadi Y (2021) Evaluation of the immunogenicity and efficacy of a chimeric OMP25-OMP31 antigen in BALB\/c mice. Vet Med Sci 7(5):2008\u20132014","journal-title":"Vet Med Sci"},{"issue":"1","key":"4796_CR95","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2206","volume":"8","author":"F Nimmerjahn","year":"2008","unstructured":"Nimmerjahn F, Ravetch JV (2008) Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8(1):34\u201347","journal-title":"Nat Rev Immunol"},{"key":"4796_CR96","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.molimm.2019.09.018","volume":"116","author":"M Nosrati","year":"2019","unstructured":"Nosrati M, Hajizade A, Nazarian S, Amani J, Namvar Vansofla A, Tarverdizadeh Y (2019) Designing a multi-epitope vaccine for cross-protection against Shigella spp: an immunoinformatics and structural vaccinology study. Mol Immunol 116:106\u2013116","journal-title":"Mol Immunol"},{"issue":"3","key":"4796_CR97","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nri3795","volume":"15","author":"SL Nutt","year":"2015","unstructured":"Nutt SL, Hodgkin PD, Tarlinton DM, Corcoran LM (2015) The generation of antibody-secreting plasma cells. Nat Rev Immunol 15(3):160\u2013171","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"4796_CR98","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/104063879700900404","volume":"9","author":"SC Olsen","year":"1997","unstructured":"Olsen SC, Stevens MG, Cheville NF, Schurig G (1997) Experimental use of a dot-blot assay to measure serologic responses of cattle vaccinated with Brucella abortus strain RB51. J Vet Diagn Invest 9(4):363\u2013367","journal-title":"J Vet Diagn Invest"},{"issue":"1","key":"4796_CR99","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/IAI.01151-08","volume":"77","author":"KA Pasquevich","year":"2009","unstructured":"Pasquevich KA, Estein SM, Garc\u00eda Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J (2009) Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4\u2009+\u2009and CD8\u2009+\u2009T cells as well as systemic and oral protection against Brucella abortus infection. Infect Immun 77(1):436\u2013445","journal-title":"Infect Immun"},{"key":"4796_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11061503","author":"AI Portilho","year":"2022","unstructured":"Portilho AI, Gimenes Lima G, De Gaspari E (2022) Enzyme-linked immunosorbent assay: an adaptable methodology to study SARS-CoV-2 humoral and cellular immune responses. J Clin Med. https:\/\/doi.org\/10.3390\/jcm11061503","journal-title":"J Clin Med"},{"issue":"17","key":"4796_CR101","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1016\/j.vaccine.2024.04.085","volume":"42","author":"I Poveda-Urkixo","year":"2024","unstructured":"Poveda-Urkixo I, Mena-Bueno S, Ram\u00edrez GA, Zabalza-Barangu\u00e1 A, Tsolis RM, Grill\u00f3 MJ (2024) Brucella melitensis Rev1\u2206wzm: placental pathogenesis studies and safety in pregnant ewes. Vaccine 42(17):3710\u20133720","journal-title":"Vaccine"},{"issue":"2","key":"4796_CR102","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2295398","volume":"55","author":"KA Qureshi","year":"2023","unstructured":"Qureshi KA, Parvez A, Fahmy NA, Abdel Hady BH, Kumar S, Ganguly A, Atiya A, Elhassan GO, Alfadly SO, Parkkila S, Aspatwar A (2023) Brucellosis: epidemiology, pathogenesis, diagnosis and treatment-a comprehensive review. Ann Med 55(2):2295398","journal-title":"Ann Med"},{"issue":"1","key":"4796_CR103","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cyto.2007.05.003","volume":"38","author":"M Rasouli","year":"2007","unstructured":"Rasouli M, Kiany S (2007) Association of interferon-gamma and interleukin-4 gene polymorphisms with susceptibility to brucellosis in Iranian patients. Cytokine 38(1):49\u201353","journal-title":"Cytokine"},{"issue":"5","key":"4796_CR104","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/QCO.0b013e3283638104","volume":"26","author":"MP Rubach","year":"2013","unstructured":"Rubach MP, Halliday JE, Cleaveland S, Crump JA (2013) Brucellosis in low-income and middle-income countries. Curr Opin Infect Dis 26(5):404\u2013412","journal-title":"Curr Opin Infect Dis"},{"key":"4796_CR105","doi-asserted-by":"crossref","unstructured":"Rutkowska DA, Du Plessis LH, Suleman E, O\u2019kennedy MM, Thimiri Govinda Raj D. B., Lemmer Y (2024) Development of a Plant-Expressed Subunit Vaccine against Brucellosis. Microorganisms, 12(6)","DOI":"10.3390\/microorganisms12061047"},{"key":"4796_CR106","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.669196","volume":"11","author":"S Ryskeldinova","year":"2021","unstructured":"Ryskeldinova S, Zinina N, Kydyrbayev Z, Yespembetov B, Kozhamkulov Y, Inkarbekov D, Assanzhanova N, Mailybayeva A, Bugybayeva D, Sarmykova M, Khairullin B, Tabynov K, Bulashev A, Aitzhanov B, Abeuov K, Sansyzbay A, Yespolov T, Renukaradhya GJ, Olsen S, O\u00f1ate A, Tabynov K (2021) Registered influenza viral vector based Brucella abortus vaccine for cattle in Kazakhstan: age-wise safety and efficacy studies. Front Cell Infect Microbiol 11:669196","journal-title":"Front Cell Infect Microbiol"},{"key":"4796_CR107","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.2147\/IJN.S249942","volume":"15","author":"Z Sadeghi","year":"2020","unstructured":"Sadeghi Z, Fasihi-Ramandi M, Bouzari S (2020) Nanoparticle-based vaccines for brucellosis: calcium phosphate nanoparticles-adsorbed antigens induce cross protective response in mice. Int J Nanomed 15:3877\u20133886","journal-title":"Int J Nanomed"},{"issue":"1","key":"4796_CR108","first-page":"36","volume":"29","author":"S Sattari Sarvari","year":"2025","unstructured":"Sattari Sarvari S, Rezaei Adriani R, Nazarian S, Fotouhi A, Mousavi Gargari SL (2025) Protective immunity of a novel multi-epitope vaccine encoding OMP31, TF, BLS, SOD, BP26, and L9 against Brucella spp. Infect Iran Biomed J 29(1):36\u201348","journal-title":"Infect Iran Biomed J"},{"issue":"2","key":"4796_CR109","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4161\/hv.2.2.2620","volume":"2","author":"JA Schalk","year":"2006","unstructured":"Schalk JA, Mooi FR, Berbers GA, Van Aerts LA, Ovelg\u00f6nne H, Kimman TG (2006) Preclinical and clinical safety studies on DNA vaccines. Hum Vaccin 2(2):45\u201353","journal-title":"Hum Vaccin"},{"issue":"2","key":"4796_CR110","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","volume":"75","author":"K Schroder","year":"2004","unstructured":"Schroder K, Hertzog PJ, Ravasi T, Hume DA (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75(2):163\u2013189","journal-title":"J Leukoc Biol"},{"issue":"1\u20134","key":"4796_CR111","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0378-1135(02)00255-9","volume":"90","author":"GG Schurig","year":"2002","unstructured":"Schurig GG, Sriranganathan N, Corbel MJ (2002) Brucellosis vaccines: past, present and future. Vet Microbiol 90(1\u20134):479\u2013496","journal-title":"Vet Microbiol"},{"issue":"3\u20134","key":"4796_CR112","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.vetmic.2009.06.021","volume":"140","author":"MN Seleem","year":"2010","unstructured":"Seleem MN, Boyle SM, Sriranganathan N (2010) Brucellosis: a re-emerging zoonosis. Vet Microbiol 140(3\u20134):392\u2013398","journal-title":"Vet Microbiol"},{"key":"4796_CR113","doi-asserted-by":"crossref","first-page":"126649","DOI":"10.1016\/j.vaccine.2024.126649","volume":"45","author":"M Serpa Gon\u00e7alves","year":"2025","unstructured":"Serpa Gon\u00e7alves M, De Oliveira MM, Andrade RS, De Oliveira LF, Guimar\u00e3es AS, Godfroid J, Lage AP, Dorneles EM (2025) S. Systematic review on the effectiveness of Brucella abortus S19 and RB51 vaccine strains in field studies. Vaccine 45:126649","journal-title":"Vaccine"},{"issue":"11","key":"4796_CR114","volume":"102","author":"D Shi","year":"2023","unstructured":"Shi D, Chen Y, Chen M, Zhou T, Xu F, Zhang C, Wang C, Li Z (2023) Bioinformatics analysis of Omp19 and Omp25 proteins for designing multi-epitope vaccines against Brucella. Medicine (Baltimore) 102(11):e33182","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"4796_CR115","volume":"14","author":"J Shi","year":"2024","unstructured":"Shi J, Zhu Y, Yin Z, He Y, Li Y, Haimiti G, Xie X, Niu C, Guo W, Zhang F (2024) In silico designed novel multi-epitope mRNA vaccines against Brucella by targeting extracellular protein BtuB and LptD. Sci Rep 14(1):7278","journal-title":"Sci Rep"},{"issue":"9","key":"4796_CR116","first-page":"957","volume":"21","author":"M Shojaei","year":"2018","unstructured":"Shojaei M, Tahmoorespur M, Soltani M, Sekhavati MH (2018) Immunogenicity evaluation of plasmids encoding Brucella melitensis Omp25 and Omp31 antigens in BALB\/c mice. Iran J Basic Med Sci 21(9):957\u2013964","journal-title":"Iran J Basic Med Sci"},{"key":"4796_CR117","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetimm.2025.110999","volume":"288","author":"R Shome","year":"2025","unstructured":"Shome R, Konda PY, Gandu S, Skariah S, Muninarayanaswamy PK, Maharana SM, Mohandoss N (2025) Post-vaccination sero-monitoring of bovine calves in Indian subcontinent: a review on progress towards brucellosis control. Vet Immunol Immunopathol 288:110999","journal-title":"Vet Immunol Immunopathol"},{"key":"4796_CR118","volume":"2011","author":"TM Silva","year":"2011","unstructured":"Silva TM, Costa EA, Paix\u00e3o TA, Tsolis RM, Santos RL (2011) Laboratory animal models for brucellosis research. J Biomed Biotechnol 2011:518323","journal-title":"J Biomed Biotechnol"},{"issue":"0","key":"4796_CR119","first-page":"e1","volume":"89","author":"GJG Simpson","year":"2018","unstructured":"Simpson GJG, Marcotty T, Rouille E, Chilundo A, Letteson JJ, Godfroid J (2018) Immunological response to Brucella abortus strain 19 vaccination of cattle in a communal area in South Africa. J S Afr Vet Assoc 89(0):e1\u2013e7","journal-title":"J S Afr Vet Assoc"},{"issue":"2 Pt A","key":"4796_CR120","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.molimm.2015.09.011","volume":"68","author":"D Singh","year":"2015","unstructured":"Singh D, Somani VK, Aggarwal S, Bhatnagar R (2015) PLGA (85:15) nanoparticle based delivery of rL7\/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: a promising alternate to traditional adjuvants. Mol Immunol 68(2 Pt A):272\u2013279","journal-title":"Mol Immunol"},{"issue":"1","key":"4796_CR121","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/iai.63.1.264-270.1995","volume":"63","author":"MG Stevens","year":"1995","unstructured":"Stevens MG, Olsen SC, Pugh GW Jr., Brees D (1995) Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51. Infect Immun 63(1):264\u2013270","journal-title":"Infect Immun"},{"issue":"2","key":"4796_CR122","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0378-1135(82)90028-1","volume":"7","author":"SS Sutherland","year":"1982","unstructured":"Sutherland SS, Le Cras DV, Robertson AG, Johnston JM, Evans RJ (1982) Serological response of cattle after vaccination and challenge with Brucella abortus. Vet Microbiol 7(2):165\u2013175","journal-title":"Vet Microbiol"},{"key":"4796_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11030658","author":"K Swetha","year":"2023","unstructured":"Swetha K, Kotla NG, Tunki L, Jayaraj A, Bhargava SK, Hu H, Bonam SR, Kurapati R (2023) Recent advances in the lipid nanoparticle-mediated delivery of mRNA vaccines. Vaccines (Basel). https:\/\/doi.org\/10.3390\/vaccines11030658","journal-title":"Vaccines (Basel)"},{"issue":"Suppl 6","key":"4796_CR124","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2105-14-S6-S3","volume":"14","author":"TE Todd","year":"2013","unstructured":"Todd TE, Tibi O, Lin Y, Sayers S, Bronner DN, Xiang Z, He Y (2013) Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella vaccines and vaccine candidates. BMC Bioinformatics 14(Suppl 6):S3","journal-title":"BMC Bioinformatics"},{"key":"4796_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/ani15020212","author":"A Uslu","year":"2025","unstructured":"Uslu A, Say\u0131n Z, Balevi A, Gulcu Y, Ergen F, Ak\u0131ner I, Denizli O, Erganis O (2025) Comparison of long-term antibody titers in calves treated with different conjunctival and subcutaneous Brucella abortus S19 vaccines. Animals (Basel). https:\/\/doi.org\/10.3390\/ani15020212","journal-title":"Animals (Basel)"},{"key":"4796_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/v17040566","author":"T Vallet","year":"2025","unstructured":"Vallet T, Vignuzzi M (2025) Self-amplifying RNA: advantages and challenges of a versatile platform for vaccine development. Viruses. https:\/\/doi.org\/10.3390\/v17040566","journal-title":"Viruses"},{"issue":"6","key":"4796_CR127","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0013185","volume":"19","author":"S Vection","year":"2025","unstructured":"Vection S, Laine CG, Arenas-Gamboa AM (2025) What do we really know about brucellosis diagnosis in livestock worldwide? A systematic review. PLoS Negl Trop Dis 19(6):e0013185","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"4796_CR128","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1128\/IAI.00761-12","volume":"80","author":"MA Vitry","year":"2012","unstructured":"Vitry MA, De Trez C, Goriely S, Dumoutier L, Akira S, Ryffel B, Carlier Y, Letesson JJ, Muraille E (2012) Crucial role of gamma interferon-producing CD4\u2009+\u2009Th1 cells but dispensable function of CD8\u2009+\u2009T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice. Infect Immun 80(12):4271\u20134280","journal-title":"Infect Immun"},{"issue":"1","key":"4796_CR129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011889","volume":"18","author":"M Vives-Soto","year":"2024","unstructured":"Vives-Soto M, Puerta-Garc\u00eda A, Rodr\u00edguez-S\u00e1nchez E, Pereira JL, Solera J (2024) What risk do Brucella vaccines pose to humans? A systematic review of the scientific literature on occupational exposure. PLoS Negl Trop Dis 18(1):e0011889","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"4796_CR130","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2174\/1389201014666131226123016","volume":"14","author":"Z Wang","year":"2013","unstructured":"Wang Z, Wu Q (2013) Research progress in live attenuated Brucella vaccine development. Curr Pharm Biotechnol 14(10):887\u2013896","journal-title":"Curr Pharm Biotechnol"},{"issue":"6","key":"4796_CR131","volume":"10","author":"X Wang","year":"2022","unstructured":"Wang X, Kang X, Pan M, Wang M, Zhang J, Song H (2022) Evaluation of the protective immune response induced by an rfbG-deficient Salmonella enterica serovar Enteritidis strain as a live attenuated DIVA (differentiation of infected and vaccinated animals) vaccine in chickens. Microbiol Spectr 10(6):e0157422","journal-title":"Microbiol Spectr"},{"key":"4796_CR132","volume":"127","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wu A, Xu Z, Zhang H, Li H, Fu S, Liu Y, Cui L, Miao Y, Wang Y, Zhumanov K, Xu Y, Sheng J, Yi J, Chen C (2024) A multi-epitope subunit vaccine based on CU\/ZN-SOD, OMP31 and BP26 against Brucella melitensis infection in BALB\/C mice. Int Immunopharmacol 127:111351","journal-title":"Int Immunopharmacol"},{"key":"4796_CR133","doi-asserted-by":"publisher","DOI":"10.3390\/biom13111650","author":"YY Wei","year":"2023","unstructured":"Wei YY, Liang S, Zhu XM, Liu XH, Lin FC (2023) Recent advances in effector research of Magnaporthe oryzae. Biomolecules. https:\/\/doi.org\/10.3390\/biom13111650","journal-title":"Biomolecules"},{"issue":"8","key":"4796_CR134","volume":"9","author":"L Wu","year":"2023","unstructured":"Wu L, Zhang G, Dang S, Zhang S, Zhao L, Zhai J (2023) Application of immunomodulatory therapy in a human brucellosis patient with pancytopenia: a case report. Heliyon 9(8):e18907","journal-title":"Heliyon"},{"key":"4796_CR135","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12020186","author":"L Wu","year":"2024","unstructured":"Wu L, Li X, Qian X, Wang S, Liu J, Yan J (2024) Lipid nanoparticle (LNP) delivery carrier-assisted targeted controlled release mRNA vaccines in tumor immunity. Vaccines. https:\/\/doi.org\/10.3390\/vaccines12020186","journal-title":"Vaccines"},{"issue":"1","key":"4796_CR136","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11515-012-1196-0","volume":"8","author":"X Yang","year":"2013","unstructured":"Yang X, Skyberg JA, Cao L, Clapp B, Thornburg T, Pascual DW (2013) Progress in Brucella vaccine development. Front Biol (Beijing) 8(1):60\u201377","journal-title":"Front Biol (Beijing)"},{"issue":"44","key":"4796_CR137","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1016\/j.vaccine.2016.09.004","volume":"34","author":"X Yang","year":"2016","unstructured":"Yang X, Clapp B, Thornburg T, Hoffman C, Pascual DW (2016) Vaccination with a \u2206norD \u2206znuA Brucella abortus mutant confers potent protection against virulent challenge. Vaccine 34(44):5290\u20135297","journal-title":"Vaccine"},{"issue":"1","key":"4796_CR138","doi-asserted-by":"crossref","first-page":"100143","DOI":"10.1016\/j.cellin.2023.100143","volume":"3","author":"J Yang","year":"2024","unstructured":"Yang J, Wang Y, Hou Y, Sun M, Xia T, Wu X (2024) [Not Available] Cell Insight 3(1):100143","journal-title":"[Not Available] Cell Insight"},{"key":"4796_CR139","volume":"10","author":"Y Yao","year":"2023","unstructured":"Yao Y, Zhang Z, Yang Z (2023) The combination of vaccines and adjuvants to prevent the occurrence of high incidence of infectious diseases in bovine. Front Vet Sci 10:1243835","journal-title":"Front Vet Sci"},{"issue":"8","key":"4796_CR140","doi-asserted-by":"crossref","first-page":"e0286358","DOI":"10.1371\/journal.pone.0286358","volume":"18","author":"Z Yin","year":"2023","unstructured":"Yin Z, Li M, Niu C, Yu M, Xie X, Haimiti G, Guo W, Shi J, He Y, Ding J, Zhang F (2023) Design of multi-epitope vaccine candidate against Brucella type IV secretion system (T4SS). PLoS ONE 18(8):e0286358","journal-title":"PLoS ONE"},{"key":"4796_CR141","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.micpath.2017.12.045","volume":"115","author":"S Yousefi","year":"2018","unstructured":"Yousefi S, Abbassi-Daloii T, Sekhavati MH, Tahmoorespur M (2018) Evaluation of immune responses induced by polymeric OMP25-BLS Brucella antigen. Microb Pathog 115:50\u201356","journal-title":"Microb Pathog"},{"key":"4796_CR142","doi-asserted-by":"crossref","unstructured":"Yang X, Goodwin ZI, Bhagyaraj E, Hoffman C, Pascual DW (2024) Parenteral Vaccination with a Live Brucella melitensis Mutant Protects against Wild-Type B. melitensis 16\u00a0M Challenge. Microorganisms, 12(1)","DOI":"10.3390\/microorganisms12010169"},{"issue":"9","key":"4796_CR143","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.vaccine.2023.01.017","volume":"41","author":"A Zabalza-Barangu\u00e1","year":"2023","unstructured":"Zabalza-Barangu\u00e1 A, Poveda-Urkixo I, Mena-Bueno S, Ram\u00edrez GA, De Bolle X, Grill\u00f3 MJ (2023) Vaccine properties of Brucella melitensis 16M\u0394wzm and reactivation of placental infection in pregnant sheep. Vaccine 41(9):1554\u20131566","journal-title":"Vaccine"},{"issue":"1","key":"4796_CR144","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1038\/s41598-019-40084-w","volume":"9","author":"F Zhang","year":"2019","unstructured":"Zhang F, Li Z, Jia B, Zhu Y, Pang P, Zhang C, Ding J (2019) The Immunogenicity of OMP31 Peptides and Its Protection Against Brucella melitensis Infection in Mice. Sci Rep 9(1):3512","journal-title":"Sci Rep"},{"key":"4796_CR145","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26083573","author":"H Zhang","year":"2025","unstructured":"Zhang H, Xing Y, Zhu J, Wu S, Gao J, Wang Y, Yu Z, Li A, Li Y, Chen X, Chen Z (2025) The Brucella effector protein BspF crotonylates TRIM38 to inhibit NF-\u03baB and MAPK signaling pathway. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26083573","journal-title":"Int J Mol Sci"},{"key":"4796_CR146","doi-asserted-by":"crossref","first-page":"100041","DOI":"10.1016\/j.jvacx.2019.100041","volume":"3","author":"S Zriba","year":"2019","unstructured":"Zriba S, Garcia-Gonzalez DG, Khalaf OH, Wheeler L, Chaki SP, Rice-Ficht A, Ficht TA, Arenas-Gamboa A (2019) M. Vaccine safety studies of Brucella abortus S19 and S19\u2206vjbR in pregnant swine. Vaccine X 3:100041","journal-title":"Vaccine X"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04796-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-04796-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04796-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:50:30Z","timestamp":1780120230000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-026-04796-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":146,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4796"],"URL":"https:\/\/doi.org\/10.1007\/s00203-026-04796-8","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"271"}}